Emerging Company Profile

Resolution: Fighting fibrosis with macrophages

Resolution is bringing macrophage cell therapies into the fibrosis arena

With £26.6 million and clinical data supporting the concept, Resolution is bringing macrophage cell therapies into the fibrosis arena.

Macrophages are emerging as one of the hottest tools in the fight against cancer, but Resolution is targeting a new application for the cells: attacking fibrosis. 

The Syncona-backed company launched in August with £26.6 million to develop